FindMyKOL
Clinical trialNCT01573962CompletedObservational

A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury

SponsorAstute Medical, Inc.Enrollment420Acute Kidney Injury
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The objective of this sample collection study is to collect blood and urine samples. This study is observational and will have no impact on the medical management of the subject.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

  • John Kellum, Ph.D.

    Professor, Critical Care Medicine, University of Pittsburgh

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Facility name not stated

    Loma Linda, California, United States

  • Facility name not stated

    Los Angels, California, United States

  • Facility name not stated

    Washington D.C., District of Columbia, United States

  • Facility name not stated

    Gainesville, Florida, United States

  • Facility name not stated

    Tampa, Florida, United States

  • Facility name not stated

    Idaho Falls, Idaho, United States

  • Facility name not stated

    Chicago, Illinois, United States

  • Facility name not stated

    Chicago, Illinois, United States

  • Facility name not stated

    Shreveport, Louisiana, United States

  • Facility name not stated

    Baltimore, Maryland, United States

  • Facility name not stated

    Ann Arbor, Michigan, United States

  • Facility name not stated

    Minneapolis, Minnesota, United States

  • Facility name not stated

    Missoula, Montana, United States

  • Facility name not stated

    Rochester, New York, United States

  • Facility name not stated

    The Bronx, New York, United States

  • Facility name not stated

    Durham, North Carolina, United States

  • Facility name not stated

    Akron, Ohio, United States

  • Facility name not stated

    Portland, Oregon, United States

  • Facility name not stated

    Pittsburgh, Pennsylvania, United States

  • Facility name not stated

    Pittsburgh, Pennsylvania, United States

  • Facility name not stated

    Nashville, Tennessee, United States

  • Facility name not stated

    Houston, Texas, United States

  • Facility name not stated

    Richmond, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 2012
Primary completion
31 Dec 2012
Completion
31 Dec 2012
Last update posted
15 Oct 2014
Registered enrollment
420
Registry id
NCT01573962

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.